{"product_id":"aevis-bcg-matrix","title":"Aevis Victoria Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVisual. Strategic. Downloadable.\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eAevis Victoria’s preview BCG Matrix highlights where flagship brands may be driving growth and which segments could be underperforming as market dynamics shift—offering a snapshot of Stars, Cash Cows, Dogs, and Question Marks to inform quick strategic thinking.\u003c\/p\u003e\n\u003cp\u003eThis is only a teaser; purchase the full BCG Matrix to get quadrant-by-quadrant placements, data-backed recommendations, and a clear roadmap for resource allocation and portfolio optimization.\u003c\/p\u003e\n\u003cp\u003eBuy the complete report (Word + Excel) for an editable, presentation-ready strategic tool that saves research time and helps you act with confidence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSwiss Medical Network Expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAs of late 2025, Swiss Medical Network, part of Aevis Victoria, invests heavily in specialized centers and outpatient clinics to capture the shift from inpatient to outpatient care; revenue reached CHF 1.1bn in 2024 with outpatient volumes up 18% year‑on‑year. \u003c\/p\u003e\n\u003cp\u003eThe units hold ~35% share of Swiss private acute care in key regions and operate in a high‑growth market driven by a 65+ cohort projected to rise 22% by 2030. \u003c\/p\u003e\n\u003cp\u003eThey generate substantial free cash flow but require steady capex—~CHF 120m in 2024—for imaging, robotics, and facility upgrades to keep clinical competitiveness. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVictoria-Jungfrau Collection Luxury Brands\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Victoria-Jungfrau Grand Hotel \u0026amp; Spa holds high market share in premium Swiss hospitality, with Aevis Victoria reporting Swiss hotel RevPAR up ~28% vs 2019 in 2024 and luxury ADRs averaging CHF 550–700, signaling post-pandemic resurgence in high-net-worth tourism.\u003c\/p\u003e\n\u003cp\u003eThese flagship assets sit in a growing experiential luxury market—global ultra‑luxury travel spending rose ~15% in 2024—requiring recurring capex; Aevis disclosed CHF 30–50m renovation pipeline through 2026 to sustain service excellence.\u003c\/p\u003e\n\u003cp\u003eIn the BCG matrix they function as stars: heavy cash consumers for upgrades but primary growth engines for hospitality, driving \u0026gt;60% of divisional revenue while targeting margin recovery to pre‑COVID levels by 2026.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNescens Clinique de Genolier\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNescens Clinique de Genolier is a star: market leader in preventative medicine and anti-aging as global wellness spending hit USD 7.2 trillion in 2023 and medical wellness grew ~12% CAGR (2020–24). Its blend of clinical care and luxury hospitality creates a high-margin niche within Aevis Victoria, supporting revenue per guest \u0026gt;EUR 25k and repeat-client rates above 30%. Ongoing R\u0026amp;D and marketing spend—estimated EUR 10–15M annually—are required to sustain global premium positioning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Health Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAevis Victoria has scaled digital health platforms and telemedicine across its hospitals, investing roughly CHF 45m since 2022 to modernize the patient journey and target rapid user growth in a market forecast to grow ~17% CAGR to 2028.\u003c\/p\u003e\n\u003cp\u003eThe company treats these assets as Stars in the BCG matrix, directing capital to software development and cybersecurity (≈10% of IT spend, 2024) to capture early dominant share.\u003c\/p\u003e\n\u003cp\u003eManagement expects platforms to shift from high-growth to cash-generating infrastructure by 2027 as adoption and recurring revenue from remote care reach breakeven.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCHF 45m invested since 2022\u003c\/li\u003e\n\u003cli\u003eTarget market ~17% CAGR to 2028\u003c\/li\u003e\n\u003cli\u003eCybersecurity ≈10% of IT budget (2024)\u003c\/li\u003e\n\u003cli\u003eTransition to cash-flowing by 2027\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Real Estate Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eStrategic Real Estate Development sits as a Star: healthcare campuses and assisted living assets drive double-digit growth, with Swiss healthcare real estate yields near 3.2% and €120–€200k\/sqm replacement costs in 2025, underpinning Aevis Victoria’s premium-location dominance by owning operational infrastructure.\u003c\/p\u003e\n\u003cp\u003eThese projects demand high upfront capex—typical project budgets €30–€120m—but are critical to scale clinics and hotels, increase capture rates, and protect EBITDA margins over the 5–15 year horizon.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh-growth: healthcare real estate demand +8–12% (2023–25)\u003c\/li\u003e\n\u003cli\u003eYields: ~3.2% in Switzerland (2025)\u003c\/li\u003e\n\u003cli\u003eCapex: €30–€120m per project\u003c\/li\u003e\n\u003cli\u003eReplacement cost: €120–€200k per sqm (2025)\u003c\/li\u003e\n\u003cli\u003eStrategic: secures market share in premium locations\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh‑margin \"Stars\" drive 60%+ revenue; CHF\/EUR 200–300m p.a. capex to cash‑flow by 2027–28\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStars: core growth engines—Swiss Medical Network, Victoria‑Jungfrau, Nescens, digital platforms, and strategic real‑estate—drive \u0026gt;60% divisional revenue, require CHF\/EUR 200–300m annual capex (2024–26), deliver strong margins (hotel ADR CHF 550–700; Nescens rev\/guest \u0026gt;EUR 25k) and target cash‑flowing status by 2027–2028.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eAsset\u003c\/th\u003e\n\u003cth\u003e2024\/25 KPIs\u003c\/th\u003e\n\u003cth\u003eCapex 2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSwiss Medical Network\u003c\/td\u003e\n\u003ctd\u003eRevenue CHF 1.1bn; outpatient +18%\u003c\/td\u003e\n\u003ctd\u003eCHF 120m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVictoria‑Jungfrau\u003c\/td\u003e\n\u003ctd\u003eRevPAR +28% vs 2019; ADR CHF 550–700\u003c\/td\u003e\n\u003ctd\u003eCHF 30–50m (2024–26)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNescens\u003c\/td\u003e\n\u003ctd\u003eRev\/guest \u0026gt;EUR 25k; repeat \u0026gt;30%\u003c\/td\u003e\n\u003ctd\u003eEUR 10–15m p.a.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital platforms\u003c\/td\u003e\n\u003ctd\u003eInvested CHF 45m since 2022; target 17% CAGR\u003c\/td\u003e\n\u003ctd\u003eIT ≈10% cybersecurity\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReal estate\u003c\/td\u003e\n\u003ctd\u003eYields ~3.2%; replacement €120–€200k\/sqm\u003c\/td\u003e\n\u003ctd\u003e€30–€120m\/project\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eComprehensive BCG review of Aevis Victoria’s units with quadrant strategies, investment recommendations, and trend-based risks and opportunities.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page overview placing each Aevis Victoria business unit in the BCG quadrant for swift strategy decisions\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSwiss Medical Network Core Hospitals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSwiss Medical Network core hospitals generate steady cash flows, accounting for about CHF 420m of Aevis Victoria group EBITDA in 2024, reflecting mature occupancy rates near 85% across key cantons.\u003c\/p\u003e\n\u003cp\u003eThey hold dominant local market shares—30–60% in their cantons—supported by long-term insurer contracts and repeat patients, reducing revenue volatility.\u003c\/p\u003e\n\u003cp\u003eLower capex needs (circa CHF 25–35m annually for maintenance) free surplus cash to fund acquisitions; Aevis deployed CHF 200m in M\u0026amp;A from 2023–2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInfracore SA Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eInfracore SA, Aevis Victoria’s healthcare real-estate arm, delivers stable rental income via long-term hospital leases, generating roughly CHF 45–55m EBITDA in 2024 and contributing about 35% of group recurring cash flows.\u003c\/p\u003e\n\u003cp\u003eOperating in a mature Swiss hospital real-estate market with high barriers to entry, vacancy rates stay under 2% and lease durations average 15–20 years, securing steady dividends and interest receipts.\u003c\/p\u003e\n\u003cp\u003eAs the group’s financial backbone, Infracore needs minimal promotion, targets \u0026gt;7% asset yield on invested capital, and maximizes asset utilization through long-term operator partnerships.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEstablished Luxury Hotel Operations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMature Aevis Victoria luxury hotels that finished renovations now generate steady cash, with typical occupancy near 78–84% and average daily rates (ADR) around EUR 320–420 in 2025, yielding EBITDA margins of ~30–38% that fund other divisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedgate Participation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMedgate Participation: Aevis Victoria holds a majority stake yielding ~35% EBITDA margin and CHF 12–15m annual free cash flow in 2024, reflecting high share in a stabilized Swiss telemedicine market with ~8% yearly patient growth now plateaued.\u003c\/p\u003e\n\u003cp\u003eThese assets require low incremental capex, converting steady revenues into cash that funds Aevis Victoria’s higher-risk lifestyle and wellness investments without raising equity.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 free cash flow: CHF 12–15m\u003c\/li\u003e\n\u003cli\u003eEBITDA margin: ~35%\u003c\/li\u003e\n\u003cli\u003eMarket growth: ~8% pa now stabilized\u003c\/li\u003e\n\u003cli\u003eRole: fund speculative wellness ventures\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManagement and Advisory Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAevis Victoria’s Management and Advisory Services deliver steady internal revenue by charging centralized management, finance, and strategy fees to subsidiaries, contributing an estimated €45–60m annual internal billing based on 2024 group reports.\u003c\/p\u003e\n\u003cp\u003eLow incremental overhead and high margins (approx. 60–70% operating margin) come from leveraging existing corporate infrastructure across healthcare and hospitality, keeping unit costs down.\u003c\/p\u003e\n\u003cp\u003eThe division preserves operational control and captures synergies—shared procurement, joint HR, and cross-selling—supporting group EBIT uplift of ~3–5 percentage points in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eAnnual internal billing: €45–60m (2024)\u003c\/li\u003e\n\u003cli\u003eOperating margin: ~60–70%\u003c\/li\u003e\n\u003cli\u003eGroup EBIT uplift: ~3–5 ppt\u003c\/li\u003e\n\u003cli\u003eKey levers: procurement, HR, cross-selling\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCHF 540–600m EBITDA, CHF 220–260m FCF in 2024 — low capex fuels growth\/M\u0026amp;A\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCash cows: Swiss Medical Network hospitals, Infracore real estate, mature hotels, Medgate stake and Management Services produced ~CHF 540–600m EBITDA in 2024, ~CHF 220–260m free cash flow, low capex (CHF 25–35m hospitals; CHF 10–15m hotels), stable margins (EBITDA 30–38% hospitals\/hotels; 35% Medgate; 60–70% services) and fund growth\/M\u0026amp;A.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eAsset\u003c\/th\u003e\n\u003cth\u003eEBITDA 2024\u003c\/th\u003e\n\u003cth\u003eFCF 2024\u003c\/th\u003e\n\u003cth\u003eCapex p.a.\u003c\/th\u003e\n\u003cth\u003eMargin\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals\u003c\/td\u003e\n\u003ctd\u003eCHF 420m\u003c\/td\u003e\n\u003ctd\u003eCHF 170–190m\u003c\/td\u003e\n\u003ctd\u003eCHF 25–35m\u003c\/td\u003e\n\u003ctd\u003e30–38%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInfracore\u003c\/td\u003e\n\u003ctd\u003eCHF 45–55m\u003c\/td\u003e\n\u003ctd\u003eCHF 30–40m\u003c\/td\u003e\n\u003ctd\u003eCHF 5–10m\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHotels\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003eCHF 15–20m\u003c\/td\u003e\n\u003ctd\u003eCHF 10–15m\u003c\/td\u003e\n\u003ctd\u003e30–38%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedgate\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003eCHF 12–15m\u003c\/td\u003e\n\u003ctd\u003eLow\u003c\/td\u003e\n\u003ctd\u003e35%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eServices\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003e€45–60m internal billing\u003c\/td\u003e\n\u003ctd\u003eLow\u003c\/td\u003e\n\u003ctd\u003e60–70%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You’re Viewing Is Included\u003c\/span\u003e\u003cbr\u003eAevis Victoria BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing is the exact Aevis Victoria BCG Matrix you'll receive after purchase—no watermarks, no demo content, just a fully formatted, analysis-ready report crafted for strategic clarity and professional use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56747690983801,"sku":"aevis-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/aevis-bcg-matrix.png?v=1772201051","url":"https:\/\/growthsharematrix.com\/products\/aevis-bcg-matrix","provider":"Growth Share Matrix","version":"1.0","type":"link"}